<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.nitrc.org/themes/nitrc3.0/css/rss.xsl.php?feed=https://www.nitrc.org/export/rss20_forum.php?forum_id=6937" ?>
<?xml-stylesheet type="text/css" href="https://www.nitrc.org/themes/nitrc3.0/css/rss.css" ?>
<rss version="2.0"> <channel>
  <title>NITRC News Group Forum: structural-and-functional-mri-of-the-brain-as-biomarker-for-postcancer-fatigue.</title>
  <link>http://www.nitrc.org/forum/forum.php?forum_id=6937</link>
  <description>
	&lt;table border=&quot;0&quot; width=&quot;100%&quot;&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;right&quot;&gt;&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;amp;cmd=Link&amp;amp;LinkName=pubmed_pubmed&amp;amp;from_uid=28021598&quot;&gt;Related Articles&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
        &lt;p&gt;&lt;b&gt;Structural and functional MRI of the brain as biomarker for postcancer fatigue.&lt;/b&gt;&lt;/p&gt;          
        &lt;p&gt;J Clin Oncol. 2011 May 20;29(15_suppl):9050&lt;/p&gt;
        &lt;p&gt;Authors:  Prinsen H, Heerschap A, Bleijenberg G, Zwarts M, van der Graaf M, Rijpkema M, Van Laarhoven H&lt;/p&gt;
        &lt;p&gt;Abstract&lt;br/&gt;
        9050 Background: Fatigue after curative cancer treatment is a frequently occurring problem, impairing quality of life. Little is known about physiological factors determining postcancer fatigue. We aim to assess if structural and/or functional magnetic resonance imaging (MRI) of the brain can be used as a biomarker for postcancer fatigue.&lt;br/&gt;
        METHODS: Severely fatigued (n=25) and matched non-fatigued (n=16) disease-free cancer survivors, who completed treatment of a malignant tumor ≥1 year earlier, participated in this case-control study. Patients with a brain tumor were excluded. Structural MRI was performed on a 3T MR system and segmentation of the brain into gray matter (GM) and white matter (WM) was carried out using a voxel-based morphometry method. Volumes of hippocampus and thalamus were obtained using FMRIB Software Library (FSL FIRST). Functional MRI by magnetic resonance spectroscopic imaging (MRSI) at 3T was used to measure N-acetylaspartate (NAA) levels in the hippocampus and the ratio of choline to creatine (Cho:Cr) in the occipital cortex. LCModel was used to analyze the (1)H-spectra. One-way ANOVA was performed and differences were considered statistically significant at p&amp;lt;0.05.&lt;br/&gt;
        RESULTS: Volumetry results (Table) showed a significantly smaller volume of the thalamus (p=0.015) in fatigued compared to non-fatigued cancer-survivors. Other MR(S)I parameters were not significantly different between severely fatigued and non-fatigued participants (Table).&lt;br/&gt;
        CONCLUSIONS: Thalamus volume was significantly smaller in fatigued compared to non-fatigued cancer-survivors. As non-motor functions of the basal ganglia play a key role in central fatigue, the thalamus, which interacts with the basal ganglia, may also contribute to fatigue. Thus, thalamus volume may serve as a possible biological marker for postcancer fatigue. [Table: see text].&lt;br/&gt;
        &lt;/p&gt;&lt;p&gt;PMID: 28021598 [PubMed - in process]&lt;/p&gt;
    </description>
  <language>en-us</language>
  <copyright>Copyright 2000-2026 NITRC OSI</copyright>
  <webMaster></webMaster>
  <lastBuildDate>Wed, 06 May 2026 1:38:21 GMT</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <generator>NITRC RSS generator</generator>
 </channel>
</rss>
